Enovis Corp(us:ENOV)
42.96
-0.37%
Updated on 2024-12-23
Open:43.00
Close:42.96
High:43.62
Low:42.81
Pre Close:43.12
Volume:360377.00
Amount:15.55M
Turnover:0.64%
Shares:55.88M
MarketCap:2.40B
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 320 | 60558928 | 110.38% | 40 | 128 | 121 |
| 2024-03-31 | 317 | 58625494 | 106.90% | 32 | 111 | 124 |
| 2023-12-31 | 324 | 57667311 | 105.62% | 64 | 120 | 105 |
| 2023-09-30 | 297 | 54233274 | 99.39% | 41 | 90 | 122 |
| 2023-06-30 | 293 | 53666437 | 98.41% | 43 | 87 | 122 |
| 2023-03-31 | 276 | 51067181 | 93.71% | 36 | 86 | 118 |
| 2022-12-31 | 280 | 52184360 | 96.23% | 41 | 94 | 111 |
| 2022-09-30 | 280 | 49732954 | 91.85% | 36 | 90 | 123 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-06-30 | T. Rowe Price Investment Management, Inc. | 6642284 | 12.11% | 53252 | 0.81% |
| 2024-06-30 | Blackrock Inc. | 5427250 | 9.89% | 92343 | 1.73% |
| 2024-06-30 | Vanguard Group Inc | 5351581 | 9.75% | 457488 | 9.35% |
| 2024-06-30 | Dimensional Fund Advisors Lp | 3154725 | 5.75% | -40007 | -1.25% |
| 2024-06-30 | Diamond Hill Capital Management Inc | 2786034 | 5.08% | 352116 | 14.47% |
| 2024-06-30 | Davenport & Co Llc | 2316112 | 4.22% | 333660 | 16.83% |
| 2024-06-30 | Royce & Associates Lp | 2057368 | 3.75% | 457308 | 28.58% |
| 2024-06-30 | Millennium Management Llc | 1919235 | 3.50% | -272324 | -12.43% |
| 2024-06-30 | Thrivent Financial For Lutherans | 1819873 | 3.32% | -4908 | -0.27% |
| 2024-06-30 | Channing Capital Management, Llc | 1712396 | 3.12% | 132946 | 8.42% |
About
Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative disease. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.
Address:2711 Centerville Road,Suite 400
Website:http://www.enovis.com
Market Movers